Drug Patents owned by Galt Pharms

1. List of Doral drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7608616 GALT PHARMS Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia
Jun, 2028

(5 years from now)

Drugs and Companies using QUAZEPAM ingredient

Market Authorisation Date: 27 December, 1985

Treatment: Method for treating insomnia while reducing the risk of an adverse drug interaction

Dosage: TABLET;ORAL

More Information on Dosage

2. List of Oravig drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7651698 GALT PHARMS Prolonged release bioadhesive therapeutic systems
Sep, 2022

(4 months ago)

US6916485 GALT PHARMS Prolonged release bioadhesive therapeutic systems
Sep, 2022

(4 months ago)

US8518442 GALT PHARMS Prolonged release bioadhesive therapeutic systems
Sep, 2022

(4 months ago)

Drugs and Companies using MICONAZOLE ingredient

Market Authorisation Date: 16 April, 2010

Treatment: Treatment of oropharyngeal candidiasis

Dosage: TABLET;BUCCAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic